

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Ko te Adalimumab-adbm he rongoā koiora e āwhina ana ki te rongoā i ngā āhuatanga autoimmune mā te whakamārie i tō pūnaha ārai mate e kaha rawa ana. Whakaarohia he rongoā whāinga e aukati ana i ngā pūmua motuhake e pā ana ki te mumura i tō tinana, e tuku ana i te oranga mai i ngā āhuatanga pēnei i te rūmātiki, te psoriasis, me te mate whekau mumura.
No tētahi karaehe tēnei rongoā e kīia nei ko ngā aukati TNF, e mahi ana mā te aukati i te pūmua tumor necrosis factor-alpha, he pūmua e whakaoho ana i te mumura. Ki te whakaeke hē tō pūnaha ārai mate i te kiko hauora, ka uru mai te adalimumab-adbm ki te whakahoki i te taurite me te whakaiti i ngā tohumate mamae.
Ko te Adalimumab-adbm he putanga koiora o te rongoā adalimumab taketake, i hangaia kia whai hua rite tonu, engari he iti ake te utu. Ko te koiora he putanga tino rite ki te rongoā koiora kua whakaaetia kē, kua whakamātauhia kia mōhio ai e whakarato ana i ngā painga rongoā rite tonu.
Ko tēnei rongoā he paturopi monoclonal, ko te tikanga he pūmua i hangaia i te taiwhanga e whai ana i ngā urupare ārai mate tūturu o tō tinana. Ko te wāhanga "adbm" he kupu tāpiritanga noa iho e āwhina ana ki te wehe i tēnei koiora motuhake mai i ētahi atu i te whānau kotahi.
Ka whiwhi koe i tēnei rongoā mā te werohanga i raro i te kiri, ko te tikanga ka uru noa iho ki raro i tō kiri, kaua ki roto i te uaua, i te uaua rānei. Mā tēnei tikanga ka taea te ngongo i te rongoā, ā, ka taea e te nuinga o ngā tūroro te whakahaere i a rātou anō i te kāinga i muri i te whakangungu tika.
Ka rongoā te Adalimumab-adbm i ētahi āhuatanga autoimmune e whakaeke hē ana tō pūnaha ārai mate i ō kiko hauora ake. Ka tohutohu pea tō tākuta i tēnei rongoā ki te kore ētahi atu rongoā i whai hua, ki te hiahia koe ki te wawaotanga kaha ake hei whakahaere i ō tohumate.
Ko ngā āhuatanga e tino pānga ana te rongoā ko te rūmātiki, e āwhina ana ki te whakaiti i te mamae me te pōhukihuki o ngā hononga, me te ārai i te kino o ngā hononga i te wā roa. He maha ngā tūroro e kite ana i te whakapai ake i ā rātou mahi o ia rā, me te kounga o te oranga.
Ko ngā āhuatanga nui e āwhina ana tēnei rongoā ki te whakahaere:
E rerekē ana te urupare o ia āhuatanga ki te rongoā, ā, ka mātakitaki tō tākuta i tō haere whakamua kia mōhio ai kei te whiwhi koe i te painga nui me te iti o ngā pānga taha.
Ka mahi a Adalimumab-adbm mā te aukati i te TNF-alpha, he pūmua e mahi ana hei karere e kī ana ki tō pūnaha ārai mate kia hanga mumura. Ki te whai koe i te āhua ārai-aunoa, ka whakaputa tō tinana i te nui rawa o te TNF-alpha, e arahi ana ki te mumura mau tonu me te kino o te kiko.
E whakaarohia ana tēnei rongoā he rongoā kaha, e whāinga ana, e aukati ana i te tukanga mumura, kaua ki te pēhi i tō pūnaha ārai mate katoa. Mā te here ki te TNF-alpha, ka ārai i tēnei pūmua mai i te piri ki ngā pūtau me te whakaoho i te tukanga mumura.
Kāore i te wātea tonu ngā pānga – ka tīmata te nuinga o te tangata ki te kite i ngā whakapainga i roto i ngā wiki 2-4, me ngā painga nui e kitea ana i muri i te 3-6 marama o te rongoā tonu. E hiahia ana tō tinana i te wā ki te whakaiti i te mumura o nāianei me te tīmata ki te whakaora i ngā kiko kua kino.
Ka hoatu a Adalimumab-adbm hei werohanga i raro i te kiri, ko te tikanga ka haere te ngira i raro i tō kiri, pērā i te tangata whai mate huka e werohia ana te insulin. Mā tō kaiwhakarato hauora e ako i a koe i te tikanga tika, ā, ka taea e te mema o te whānau te ako ki te āwhina i a koe.
Ko ngā wāhi weronga ka huri haere i waenga i tō huha me te puku, me te karo i ngā wāhi e pāwera ana, e pā ana te pānga, e whara ana rānei. Me tuku te rongoā kia tae ki te pāmahana rūma i mua i te weronga, nā te mea ka whakaiti i te kore whakamarie.
Ko te nuinga o te tangata ka werohia i ngā wiki kē, ahakoa ka whakatika pea tō tākuta i tēnei hōtaka i runga i tō āhuatanga me tō urupare. He mea nui kia piri ki tō hōtaka kua whakaritea, nā te mea ko ngā taumata rongoā e mau tonu ana i tō tinana ka whai hua pai.
Kāore koe e hiahia ki te tango i tēnei rongoā me te kai, engari ko te pupuri i te kai hauora ka tautoko i tō angitu maimoatanga whānui. E kitea ana e ētahi tāngata he āwhina ki te werohia i te wā kotahi i ia wiki ki te whakatū i tētahi tikanga.
Ko te roa o te maimoatanga me te adalimumab-adbm he rerekē rawa i runga i tō āhuatanga me te pai o tō urupare ki te rongoā. He maha ngā tāngata e mate ana i ngā āhuatanga autoimmune mau tonu e tango ana i tēnei rongoā mō ngā tau ki te pupuri i te mana whakahaere tohu me te ārai i te haere whakamua o te mate.
Ka arotakehia e tō tākuta tō ahunga whakamua i ngā wā katoa mā ngā whakamātautau toto, ngā whakamātau tinana, me ngā kōrero mō ō tohu. Ki te pai ana koe, ko te haere tonu i te maimoatanga ka ārai i ngā pūremu me te tiaki i ngā raruraru wā roa.
Ka taea e ētahi tāngata te whakaiti i tā rātou horopeta, te whakanui rānei i te wā i waenga i ngā weronga i te wā e pai ana te whakahaere i tō rātou āhuatanga. Heoi, ko te whakamutu ohorere me te kore he tirotiro hauora ka arahi ki te hokinga mai o ngā tohu, nō reira me kōrero tonu ngā huringa ki tō kaiwhakarato hauora.
Ko te whāinga ko te kimi i te taurite tika i waenga i te whakahaere i tō āhuatanga me te whakaiti i ngā pānga wā roa o te rongoā.
Pērā i ngā rongoā katoa, ka pānga ngā pānga taha ki te adalimumab-adbm, ahakoa he maha ngā tāngata e pai ana ki te tango. Ko ngā pānga taha tino noa he ngawari, he mārama hoki, engari ko ngā urupare nui he iti noa iho, engari me āta tirotiro tonu.
Mā te māramatanga ki ngā mea e tūmanakohia ana ka āwhina koe ki te whai i te māia ki tō rongoā, me te mōhio ki te wā ki te whakapā atu ki tō kaiwhakarato hauora.
Ko ngā pānga taha noa ka pā ki a koe ko:
He maha ngā wā ka pai ake ēnei tohumate i te wā e urutau ana tō tinana ki te rongoā, i roto i ngā marama tuatahi o te rongoā.
Ko ngā pānga taha nui ake me āta tirotiro tonu, ko:
Ka āta aroturukihia koe e tō tākuta mō ēnei pānga mā ngā arowhai auau me ngā whakamātautau toto, ina koa i roto i ngā marama tuatahi o te rongoā.
Ka puta i ētahi wā ngā āhuatanga onge engari nui, tae atu ki ētahi momo mate pukupuku, ngā mate nui, te whakahohenga anō rānei o ngā mate huna pērā i te mate kohi. Ka arotakehia e tō kaiwhakarato hauora ēnei tūponotanga i mua i te tīmatanga o te rongoā, me te aroturuki tonu i te wā o tō rongoā.
Kāore a Adalimumab-adbm e tika ana mō te katoa, ā, ka āta arotake tō tākuta mō te haumaru mōu i runga i tō hītori hauora me te āhua o tō hauora i tēnei wā. Ko ētahi āhuatanga, ko ētahi wāhi rānei, ka waiho tēnei rongoā hei mea kino, kaua hei mea whai hua.
Kāore koe e tango i tēnei rongoā mēnā he mate urutā tōna, nā te mea ka pēhi i te kaha o tō pūnaha ārai mate ki te whawhai i ngā huakita, ngā huaketo, ngā harore rānei. Kei roto i tēnei ngā mate urutā e kitea ana me ngā mea huna kāore anō kia puta ngā tohumate.
Ko ngā tāngata e whai ana i ngā āhuatanga e whai ake nei, kāore e taea te tango i te adalimumab-adbm:
Ka tūpato anō tō tākuta mēnā he mate huka tōna, he COPD rānei, ētahi atu āhuatanga rānei e pā ana ki tō pūnaha ārai mate, nā te mea ka piki ake pea tō tūponotanga ki ngā raruraru.
Me whai whakaaro motuhake te hapū me te whāngai u, nā te mea ka taea e te rongoā te whiti i te pūhihi, ā, ka pā pea ki te pēpi e whanake ana. Ka whakataurite tō tākuta i ngā painga ki ngā tūponotanga i ēnei wā.
Kei te wātea te Adalimumab-adbm i raro i te ingoa waitohu Cyltezo, he mea hanga e Boehringer Ingelheim. I whakaaetia tēnei biosimilar e te FDA hei momo rongoā utu iti ake i te rongoā adalimumab taketake.
Ka taea hoki e tō whare rongoā te kī atu ki a ia i tōna ingoa whānui katoa, adalimumab-adbm, e āwhina ana ki te wehe i a ia i ētahi atu biosimilars adalimumab he rerekē ngā reta suffix. E mahi ana te rongoā i te ara kotahi ahakoa ko tēhea ingoa e puta ana i runga i tō tapanga rongoā.
Ka rerekē pea te kapinga inihua i waenga i ngā hua adalimumab rerekē, nā reira ka mahi tō tākuta me tō kai rongoā kia mōhio kei te whiwhi koe i te kōwhiringa tino whai hua e tutuki ana i ō hiahia maimoatanga.
He maha ngā rongoā kē e mahi ana i te ara rite ki te adalimumab-adbm mā te aro ki ngā wāhanga rerekē o te pūnaha ārai mate. Ka whakaaro pea tō tākuta i ēnei kōwhiringa mēnā kāore koe e aro pai ki te adalimumab, ki te pā rānei i ngā pānga taha e kore ai e tika māu.
Ko ētahi atu aukati TNF ko te etanercept, infliximab, me te certolizumab, he rerekē ngā tikanga whakahaere me ngā kōrero mō ngā pānga taha. Ko ētahi tāngata e pai ake ana ki tētahi aukati TNF i tētahi atu, nā reira ka taea e te huri i waenga i a rātou te whakapai ake i ngā hua.
E tuku ana ngā koiora kore-TNF i ngā tikanga mahi rerekē, kei roto ko ngā rongoā pēnei i te rituximab, abatacept, me te tocilizumab. E aro ana ēnei ki ngā pūmua pūnaha ārai mate rerekē, ā, ka whai hua pea i te wā kāore ngā aukati TNF e whai hua ana.
Ko ngā rongoā tuku iho pēnei i te methotrexate, sulfasalazine, me te corticosteroids te mea nui tonu hei kōwhiringa maimoatanga, e whakamahia ana i te nuinga o te wā i te taha o ngā koiora, hei rongoā motuhake rānei mō ngā keehi ngawari.
Kei roto i te Adalimumab-adbm me te Humira te mea kaha kotahi, ā, e mahi ana i ngā ara rite tonu ki te rongoā i ngā āhuatanga ārai mate. Ko te rerekētanga nui ko te adalimumab-adbm he koiora rite, ko te tikanga he putanga tino rite ki te Humira kua whakamātauhia kia mōhio ai he rite te whai huatanga me te haumaru.
E whakaatu ana ngā rangahau haumanu e whakaputa ana te adalimumab-adbm i ngā hua rongoā rite ki te Humira, kāore he rerekētanga nui i te pai o te whakahaere i ngā tohu, i te aukati rānei i te haere whakamua o te mate. He rite tonu ngā kōrero mō ngā pānga taha o ngā rongoā e rua, ā, e hiahia ana i te aroturuki rite.
Ko te painga tuatahi o te adalimumab-adbm ko te utu, na te mea he iti ake te utu o nga rongoa rite ki te rongoa taketake. Ma tenei ka ngawari ake te uru atu ki te maimoatanga me te whakaiti i o whakapaunga, ina koa mehemea e hiahia ana koe ki te rongoa mo te wa roa.
Ka whiriwhiria e to taakuta i waenga i enei whiringa i runga i to inihua, i to hiahia ake, me te waatea, me te mohio ka rite tonu nga painga rongoa e rua.
Me ata whakaaro te Adalimumab-adbm mehemea he mate ngakau koe, ina koa te ngoikore o te ngakau. Ka taea e te rongoa te whakapōrearea i ngā tohu o te ngoikore o te ngakau i roto i ētahi tāngata, ina koa ko te hunga he raruraru ngakau ngawari ki te kaha.
Ka arotakehia e tō tākuta tō hauora ngākau i mua i te whakahau i tēnei rongoa, pea tae atu ki te echocardiogram, ētahi atu whakamātautau ngākau rānei. Ki te he raruraru ngakau ngawari ō, ka taea tonu pea e koe te tango adalimumab-adbm me te aroturuki tata.
Kōrero atu ki tō tākuta tonu mehemea ka puta mai he tohu hou, he kino rānei pērā i te poto o te manawa, te pūhihi i ō waewae, te mamae rānei o te uma i te wā e tango ana koe i tēnei rongoa.
Mēnā ka werohia e koe te nui rawa o te adalimumab-adbm i te mea i whakahaua, whakapā atu ki tō kaiwhakarato hauora tonu mō te tohutohu. Ahakoa he onge te nui rawa o te horopeta ki tēnei rongoa, ka nui ake te tūponotanga o ngā pānga taha kino, ina koa ngā mate.
Kaua e tatari kia kite mehemea ka puta mai ngā tohu – waea atu ki tō tākuta tonu, ahakoa kei te pai koe. Ka hiahia pea rātou ki te aroturuki i a koe kia tata ake mō ngā tohu o te mate, ētahi atu raruraru rānei i roto i ngā wiki e whai ake nei.
Puritia te pōkai rongoa me te tuhi tika i te nui atu i tangohia e koe, nā te mea ka āwhina tēnei mōhiohio i tō kaiwhakarato hauora ki te whakatau i te ara pai.
Ki te ngaro koe i te horopeta o adalimumab-adbm, tangohia i te wa e mahara ana koe, ki te kore e tata ana te wa mo to horopeta e whai ake nei. I taua keehi, pekehia te horopeta i ngaro, ka hoki ki to waarangi auau – kaua e rua nga horopeta.
Ko te ngaro i nga horopeta i etahi wa kaore e whara tonu, engari he mea nui te rite ki te pupuri i nga taumata pumau o te rongoa i roto i to tinana. Whakamātauria te whakarite whakamaharatanga i runga i to waea, te tohu ranei i nga ra werohanga i runga i to maramataka.
Ki te wareware pinepine koe i nga horopeta, korero ki to taakuta mo nga rautaki hei awhina i a koe ki te mahara, penei i te whakatikatika me etahi atu rongoa, mahi ranei i roto i to mahi.
Kaua rawa e whakamutu i te tango adalimumab-adbm me te kore e korero ki to taakuta i te tuatahi, ahakoa kei te pai ake koe. Ko te whakamutu ohorere ka arahi ki te hokinga mai o o tohu, i etahi wa he kaha ake i mua i to tiimata i te maimoatanga.
Ma to taakuta koe e awhina ki te whakatau mena me te wa e tika ana ki te whakaiti i to horopeta, ki te whakamutu ranei i te rongoa katoa. Kei runga tenei whakatau i te pai o te whakahaere i to ahuatanga, te roa o to noho i roto i te murunga, me to tupono ki te mura.
Ka taea e etahi tangata te angitu ki te whakaiti i te rongoa i muri i nga tau o te murunga pumau, ko etahi atu me haere tonu te maimoatanga mo te wa roa hei aukati i te ahunga whakamua o te mate. Ma to ahuatanga takitahi e arahi i tenei whakatau nui.
Kaua koe e whiwhi kano kano ora i te wa e tango ana i te adalimumab-adbm, na te mea kare pea to punaha aukati i te kaha ki te whakahaere i a raatau. Kei roto i nga kano kano ora te rewharewha, te mumps, te rubella, te varicella (chickenpox), me nga kano kano rewharewha nasal.
Heoi anō, ka taea e koe, ā, me whiwhi koe i ngā kano ārai mate kua whakakorengia, pērā i te pūtu rewharewha, te kano ārai mate pneumonia, me ngā kano ārai mate COVID-19. He mea nui ēnei nā te mea he paku pēhi tō pūnaha ārai mate e te rongoā.
Me kōrero tonu ki tētahi kaiwhakarato hauora mō tō maimoatanga adalimumab-adbm i mua i te whiwhi kano ārai mate, me te ngana ki te tiki i ngā kano ārai mate e tūtohutia ana i mua i te tīmatanga o tēnei rongoā i te wā e taea ana.
Get clear medical guidance
on symptoms, medications, and lab reports.